Kari Natunen

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of <i>three cohorts from randomized trials</i>

Matti Lehtinen, Camilla Lagheden, Tapio Luostarinen et al. · BMJ Open · 2017 · 88 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Impact of gender‐neutral or girls‐only vaccination against human papillomavirus—Results of a community‐randomized clinical trial (I)

Anna Söderlund‐Strand, Simopekka Vänskä, Tapio Luostarinen et al. · International Journal of Cancer · 2017 · 68 citations

Veterinary Medicine, Community Health, Preventive Medicine +15

Gender‐neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)

Tapio Luostarinen, Simopekka Vänskä, Anna Söderlund‐Strand et al. · International Journal of Cancer · 2018 · 66 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial

Matti Lehtinen, Dan Apter, Iacopo Baussano et al. · Vaccine · 2015 · 57 citations · Full text

Veterinary Medicine, Pediatrics, Preventive Medicine +17

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied

Simopekka Vänskä, Tapio Luostarinen, Iacopo Baussano et al. · The Journal of Infectious Diseases · 2020 · 57 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +16